HEPA - Hepion Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Edison,
United States
Type: Equity
HEPA price evolution
HEPA
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2.12 | $13.11 | $14.79 | $19.28 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $5.48 | $15.43 | $17.49 | $21.27 |
| Long term investments | ||||
| Property, plant & equipment | $0.15 | $0.18 | $0.24 | $0.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.53 | $0.56 | $0.61 | $3.73 |
| Total investments | ||||
| Total assets | $6.01 | $15.99 | $18.09 | $25 |
| Current liabilities | ||||
| Accounts payable | $0.45 | $1.5 | $2.35 | $3.01 |
| Deferred revenue | ||||
| Short long term debt | $0.15 | $0.13 | $0.12 | $0.11 |
| Total current liabilities | $0.98 | $2.57 | $5.29 | $6.4 |
| Long term debt | $0.04 | $0.09 | $0.13 | |
| Total noncurrent liabilities | $1.47 | $5.89 | $5.52 | $2.44 |
| Total debt | $0.15 | $0.18 | $0.21 | $0.24 |
| Total liabilities | $2.45 | $8.47 | $10.81 | $8.84 |
| Shareholders' equity | ||||
| Retained earnings | -$231.41 | -$227.48 | -$224.63 | -$213.57 |
| Other shareholder equity | -$0.05 | $0.01 | -$0.08 | -$0.09 |
| Total shareholder equity | $3.56 | $7.52 | $7.28 | $16.16 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.79 | $51.19 | $91.35 | $40.73 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $17.49 | $56.5 | $97.45 | $42.63 |
| Long term investments | ||||
| Property, plant & equipment | $0.24 | $0.13 | $0.46 | $0.66 |
| Goodwill & intangible assets | $1.87 | $1.87 | ||
| Total noncurrent assets | $0.61 | $3.75 | $6.1 | $6.01 |
| Total investments | ||||
| Total assets | $18.09 | $60.24 | $103.55 | $48.65 |
| Current liabilities | ||||
| Accounts payable | $2.35 | $2.67 | $2.45 | $3.72 |
| Deferred revenue | ||||
| Short long term debt | $0.12 | $0.05 | $0.27 | $0.28 |
| Total current liabilities | $5.29 | $7.89 | $8.21 | $4.66 |
| Long term debt | $0.09 | $0.05 | $0.47 | |
| Total noncurrent liabilities | $5.52 | $2.5 | $2.35 | $3.46 |
| Total debt | $0.21 | $0.05 | $0.32 | $0.75 |
| Total liabilities | $10.81 | $10.39 | $10.56 | $8.12 |
| Shareholders' equity | ||||
| Retained earnings | -$224.63 | -$175.7 | -$133.5 | -$104.11 |
| Other shareholder equity | -$0.08 | -$0.09 | $0.86 | |
| Total shareholder equity | $7.28 | $49.86 | $93 | $40.52 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $7.14 | $2.54 | $5.44 | $8.52 |
| Selling, general & administrative | $1.37 | $2.64 | $1.78 | $2.15 |
| Total operating expenses | $8.5 | $5.18 | $10.41 | $10.66 |
| Operating income | -$8.5 | -$5.18 | -$10.41 | -$10.66 |
| Income from continuing operations | ||||
| EBIT | -$3.97 | -$5.82 | -$11.47 | -$10.52 |
| Income tax expense | -$2.97 | -$0.41 | ||
| Interest expense | -$0.05 | $0 | $0 | $0 |
| Net income | ||||
| Net income | -$3.93 | -$2.85 | -$11.06 | -$10.53 |
| Income (for common shares) | -$3.93 | -$2.85 | -$11.06 | -$10.53 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $35.64 | $33.27 | $20.4 | $12 |
| Selling, general & administrative | $9.62 | $10.35 | $10.01 | $8.15 |
| Total operating expenses | $48.45 | $45.49 | $30.4 | $20.15 |
| Operating income | -$48.45 | -$45.49 | -$30.4 | -$20.15 |
| Income from continuing operations | ||||
| EBIT | -$49.33 | -$45.07 | -$32.71 | -$20.29 |
| Income tax expense | -$0.41 | -$2.88 | $0.03 | |
| Interest expense | $0.01 | $0.01 | $0.01 | $0.03 |
| Net income | ||||
| Net income | -$48.93 | -$42.2 | -$32.72 | -$20.35 |
| Income (for common shares) | -$48.93 | -$45.34 | -$32.72 | -$20.36 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$3.93 | -$2.85 | -$11.06 | -$10.53 |
| Operating activities | ||||
| Depreciation | $0.03 | $0.01 | $0.02 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.03 | $0.71 | $0.15 | $0.32 |
| Total cash flows from operations | -$10.93 | -$3.62 | -$9 | -$11.24 |
| Investing activities | ||||
| Capital expenditures | -$0 | $0 | ||
| Investments | ||||
| Total cash flows from investing | -$0 | $0 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.85 | $4.49 | ||
| Net borrowings | ||||
| Total cash flows from financing | $1.85 | $4.49 | ||
| Effect of exchange rate | -$0.06 | $0.09 | $0.01 | -$0 |
| Change in cash and equivalents | -$10.99 | -$1.68 | -$4.5 | -$11.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$48.93 | -$42.2 | -$32.72 | -$20.35 |
| Operating activities | ||||
| Depreciation | $0.07 | $0.08 | $0.09 | $0.03 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.34 | $2.55 | $4.67 | $2.38 |
| Total cash flows from operations | -$40.89 | -$34.96 | -$31.22 | -$16.17 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0.13 | -$0.09 |
| Investments | ||||
| Total cash flows from investing | -$0.01 | -$0.01 | -$0.13 | -$0.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.49 | $82.15 | $42.88 | |
| Net borrowings | -$0.18 | $0.18 | ||
| Total cash flows from financing | $4.49 | -$5.14 | $81.98 | $43.05 |
| Effect of exchange rate | $0.01 | -$0.05 | ||
| Change in cash and equivalents | -$36.4 | -$40.16 | $50.62 | $26.8 |
News
Fundamentals
| Market cap | $4.00M |
|---|---|
| Enterprise value | $2.04M |
| Shares outstanding | 5.80M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$31.72M |
| EBIT | -$31.78M |
| Net Income | -$28.37M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.14 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -0.06 |
| EV/EBIT | -0.06 |
| P/S ratio | N/A |
| P/B ratio | 1.11 |
| Book/Share | 0.62 |
| Cash/Share | 0.36 |
| EPS | -$4.89 |
|---|---|
| ROA | -174.30% |
| ROE | -328.66% |
| Debt/Equity | 1.49 |
|---|---|
| Net debt/EBITDA | -0.01 |
| Current ratio | 5.62 |
| Quick ratio | 5.62 |